BI
ProShares - UltraShort Nasdaq Biotechnology (BIS)
NASDAQ·Financial Services·Asset Management
$13.71
+1.74%
Mkt Cap $1.85M
Analyst Ratings
No recent rating data.
Price Target (28 analysts)
$228.85
Range $155.22 – $268.65
Implied Upside
+1569.2%
Consensus $228.85 vs current $13.71